Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 3:05 PM
Ignite Modification Date:
2025-12-24 @ 3:05 PM
NCT ID:
NCT00705159
Eligibility Criteria:
Inclusion Criteria:
* children 0-6 years of age.
* clinical diagnosis of blepharoconjunctivitis
* Parent/guardian must understand, be willing and able to comply with all treatment and follow-up procedures.
* Parent/guardian must understand, be willing and able to provide informed consent and Health Insurance Portability Accountability Act (HIPAA) authorization.
Exclusion Criteria:
* Known hypersensitivity to corticosteroids, aminoglycosides, or any component of the study medication.
* Subjects who have a history of ocular surgery, including laser procedures, within the past 6 months.
* Subjects who are monocular.
* Subjects who have a history of any severe/serious ocular pathology or medical condition that could result in the subject's inability to complete the study.
* Subjects who have participated in an ophthalmic drug or device research study within 30 days prior to entry in this study.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
1 Week
Maximum Age:
6 Years
Study:
NCT00705159
Study Brief:
Protocol Section:
NCT00705159